Sharp Therapeutics
Vivasc Therapeutics Inc., based in Pittsburgh, PA, specializes in innovative drug delivery systems focused on reversing the effects of heart failure and treating atrial fibrillation. Utilizing their proprietary Cardiac Targeting Peptide, they aim to deliver therapeutic agents specifically to cardiomyocytes, addressing underlying cellular dysfunction rather than merely alleviating symptoms associated with heart diseases.
Founded in 2020, the company has engaged in several STTR Phase I projects, demonstrating significant advancements in delivery methods for treatment options like miRNA and amiodarone, designed to target heart tissues with precision. Their research holds promise for improving patient outcomes by mitigating adverse effects commonly related to current heart failure and arrhythmia treatments.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.


